kidney transplant

By Chris Udochukwu

Abuja, (Precise Post) – Vice President Kashim Shettima has revealed that Nigeria is experiencing a surge in reverse medical tourism, with an increasing number of international patients, particularly from the United States, seeking kidney transplants at Nigerian hospitals.

The Vice President highlighted that the affordability of medical care and the high-quality expertise available in the country are major factors attracting foreign patients. Speaking on Thursday during a courtesy visit by the Nigerian Association of Nephrology (NAN) at the Presidential Villa, Shettima noted that recent developments, including the arrival of 13 patients from the U.S. for kidney transplants at Zenith Medical and Kidney Centre, underscore the growing appeal of Nigerian healthcare facilities.

This was contained in a statement signed by the Senior Special Assistant to The President on Media & Communications (Office of The Vice President) Stanley Nwokocha released on X account of Bayo Onanuga.

“The level of care at some of our hospitals has sparked a significant reverse medical tourism trend. Recently, 13 patients from the United States came to Nigeria for kidney transplants at Zenith Medical and Kidney Centre. The cost is much more affordable here, while the quality of care is on par with any international standard,” he said.

Shettima praised Dr. Olalekan Olatise, the Chief Medical Director of Zenith Medical and Kidney Centre, for his significant contributions to advancing kidney care in the country. Describing him as a “highly altruistic” individual, the Vice President commended his efforts to assist people in need of medical care.

However, Shettima also pointed out the financial strain faced by many patients undergoing kidney transplants, with some selling their homes or relying on government support to afford the procedure. He emphasized that life after transplant poses additional challenges, particularly due to the high cost of post-transplant care, including essential immunosuppressants.

“While the kidney transplant itself is a major hurdle, the post-transplant life presents even greater challenges. Many patients face immense financial burdens, particularly for ongoing treatments and medications required for their recovery,” he added.

Reflecting on his tenure as Governor of Borno State, Shettima shared his experience in improving healthcare accessibility, including introducing free maternal care programs. He highlighted the success of one hospital in his neighborhood, which records over 30 births daily, far exceeding the capacity of larger facilities like the University of Maiduguri Teaching Hospital (UMTH).

“We’ve provided vital support to mothers, such as distributing bags of rice and beans to new mothers. Over 4,000 deliveries have been recorded in less than eight months, and all medical expenses, including caesarean sections, are covered,” he said.

Shettima also reiterated the need for Nigeria to focus on developing its medical workforce. He shared how, during his time as Governor, he took 60 female students to Sudan for medical training, with 58 completing their education and passing licensing exams. Many of these women are now pursuing medical residencies and are more likely to return to serve their communities.

“We must make deliberate investments in specialized medical education to ensure a strong, self-sustaining healthcare workforce,” Shettima emphasized.

In anticipation of the upcoming 37th Scientific Conference of the Nigerian Association of Nephrology (NAN), Dr. Olatise, who serves as Chairman of the Local Organizing Committee, announced that the event will take place in Abuja from February 19-21, 2025. The theme for the conference will be “Revolutionizing Kidney Care in Nigeria: Evidence-Based Innovations.”

The Nigerian Association of Nephrology also revealed plans to honor Vice President Shettima with the Kidney Champion Award in recognition of his ongoing advocacy and support for kidney patients, including his efforts to fund immunosuppressants and propose the establishment of a specialized laboratory for post-transplant care.